Targeted treatment for KRAS/BRAF-mutated and BCL2L1-amplified CRCs
Ontology highlight
ABSTRACT: A novel combination treatment targeting BCL2L1 and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified colorectal cancers
PROVIDER: PRJEB20153 | ENA |
REPOSITORIES: ENA
ACCESS DATA